Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19): Part III

Emmanuel J Favaloro, Giuseppe Lippi

Research output: Contribution to journalEditorialpeer-review

12 Citations (Scopus)

Abstract

Welcome to another issue of Seminars in Thrombosis and Hemostasis (STH). This issue is published under the “continuing banner” of “Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19),” this being Part III, or the third such issue. The first two issues were respectively published in 2020[1] and 2021[2] and proved very popular with the STH readership. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Believed to originate from Wuhan City in China, with the first reported case in December 2019, at time of writing, there were over 200 million cases reported worldwide, and over 4.3 million attributable deaths.[3]
Original languageEnglish
Pages (from-to)3-7
Number of pages5
JournalSeminars in Thrombosis and Hemostasis
Volume48
Issue number1
DOIs
Publication statusPublished - 01 Feb 2022

Fingerprint

Dive into the research topics of 'Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19): Part III'. Together they form a unique fingerprint.

Cite this